Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT20111212008384N9Phase 3Completed
Phase 3 trial of metformin in hyperglycemia (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: Blood sugar. Started Mar 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT20111212008384N9.